Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical management of psoriatic arthritis
Filip Van den Bosch, Laura C. Coates
The Lancet (2018) Vol. 391, Iss. 10136, pp. 2285-2294
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Psoriasis
C.E.M. Griffiths, April W. Armstrong, Jóhann E. Guðjónsson, et al.
The Lancet (2021) Vol. 397, Iss. 10281, pp. 1301-1315
Closed Access | Times Cited: 1419
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
Yoshiya Tanaka, Yiming Luo, John J. O’Shea, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 3, pp. 133-145
Open Access | Times Cited: 329
More Than Suppression: Glucocorticoid Action on Monocytes and Macrophages
Jan Ehrchen, Johannes Roth, Katarzyna Barczyk‐Kahlert
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 159
The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases
Rasoul Mirzaei, Farhad Zamani, Marzieh Hajibaba, et al.
Journal of Neuroimmunology (2021) Vol. 358, pp. 577640-577640
Closed Access | Times Cited: 86
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries
Adrian Ciurea, Seraphina Kissling, Andrea Götschi, et al.
Arthritis Research & Therapy (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis
Eric Gracey, Dominika Hromadová, Melissa Lim, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 1863-1878
Open Access | Times Cited: 66
Insights into the treatment of rheumatoid arthritis: A paradigm in medicine
Josef S Smolen
Journal of Autoimmunity (2020) Vol. 110, pp. 102425-102425
Closed Access | Times Cited: 60
Cutaneous and Systemic Psoriasis: Classifications and Classification for the Distinction
Bing‐Xi Yan, Xueyan Chen, Li‐Ran Ye, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 51
Clinical features of psoriatic arthritis
Mitsumasa Kishimoto, Gautam A. Deshpande, Kazuhito Fukuoka, et al.
Best Practice & Research Clinical Rheumatology (2021) Vol. 35, Iss. 2, pp. 101670-101670
Closed Access | Times Cited: 46
Synovial joint-on-a-chip for modeling arthritis: progress, pitfalls, and potential
Zhong Li, Shilpa Sant, Sung Kwon Cho, et al.
Trends in biotechnology (2022) Vol. 41, Iss. 4, pp. 511-527
Open Access | Times Cited: 36
Efficacy and safety of Janus kinase inhibitors in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Fan Yang, Chaofan Lu, Yanhong Wang, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 6, pp. 1593-1605
Closed Access | Times Cited: 17
Exosomes in chronic inflammatory skin diseases and skin tumors
Wen‐Ming Wang, Chao Wu, Hong‐Zhong Jin
Experimental Dermatology (2018) Vol. 28, Iss. 3, pp. 213-218
Open Access | Times Cited: 54
Predicting the Risk of Psoriatic Arthritis in Plaque Psoriasis Patients: Development and Assessment of a New Predictive Nomogram
Panpan Liu, Yehong Kuang, Li Ye, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 25
The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: Similarities and differences
Laura C. Coates, Laure Gossec
Joint Bone Spine (2022) Vol. 90, Iss. 1, pp. 105469-105469
Open Access | Times Cited: 25
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis
Proton Rahman, Wolf‐­Henning Boehncke, Philip J. Mease, et al.
The Journal of Rheumatology (2023) Vol. 50, Iss. 6, pp. 769-780
Open Access | Times Cited: 13
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel
Laura C. Coates, Marwan Bukhari, Antoni Chan, et al.
Lara D. Veeken (2024)
Open Access | Times Cited: 5
Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: A systematic review and network meta-analysis
Chenyang Lu, Beth Wallace, Akbar K. Waljee, et al.
Seminars in Arthritis and Rheumatism (2019) Vol. 49, Iss. 3, pp. 381-388
Closed Access | Times Cited: 37
Total-Body 18F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations
Yasser G. Abdelhafez, S. P. Raychaudhuri, Dario F. Mazza, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. 10, pp. 1579-1585
Open Access | Times Cited: 22
Targeted Therapies in Psoriatic Arthritis—An Update
Sonia Sundanum, Carl Orr, Douglas J. Veale
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6384-6384
Open Access | Times Cited: 12
Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis
Mathias Cardner, Danny Tuckwell, Anna Kostikova, et al.
RMD Open (2023) Vol. 9, Iss. 2, pp. e003042-e003042
Open Access | Times Cited: 11
Refractory psoriatic arthritis: emerging concepts in whole process management
Haili Xu, Ziye Wang, Liling Xu, et al.
Clinical Rheumatology (2025)
Closed Access
Cross-sectional study of proteomic differences between moderate and severe psoriasis
Lingling Wu, Cen Chen, Bibo Xie, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review
Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, et al.
Reumatismo (2025)
Open Access
Selective disruption of Traf1/cIAP2 interaction attenuates inflammatory responses and rheumatoid arthritis
Yitian Tang, Fatemah Aleithan, Sahib Singh Madahar, et al.
Journal of Autoimmunity (2025) Vol. 152, pp. 103377-103377
Open Access
An integrated multi-omics analysis identifies protein biomarkers and potential drug targets for psoriatic arthritis
Yixin Cai, Danying Zheng, Xiaoli Chen, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top